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Abstract
Background: Acacia ataxacantha is a medicinal specie used extensively in traditional medicine of Benin republic to
treat infectious diseases. Our previous study showed interesting antibacterial and antifungal activities against six
strains of bacteria and six strains of fungi. The aim of this study was to investigate the antimicrobial and antioxidant
activities of compounds isolated from A. ataxacantha.
Methods: Chromatographic and spectroscopic methods were used to isolate and identify three compounds (1–3)
from the bark of A. ataxacantha. Phytochemical investigation of A. ataxacantha (Fabaceae) led to the isolation of
three triterpenoids (1–3). The structure of isolated compounds was established by differents spectroscopic methods
such as UV, 1H NMR, 13C NMR, 2D NMR and Mass. All isolated compounds were tested for antimicrobial activity
using agar disc-diffusion and microdilution methods. The radical scavenging activity of isolated compounds was
assessed using 2,2-diphenyl-1-picrylhydrazyl (DPPH) method.
Results: Phytochemical investigation led to the isolation and identification of lupeol (1), betulinic acid (2) and
betulinic acid-3-trans-caffeate (3). Moderate antimicrobial activity was obtained with compound 3 against
methicillin-resitant Staphylococcus aureus, Enterococcus feacalis and Pseudomonas aeruginosa with MIC value of
25 μg/ml and Staphylococcus aureus (MIC of 50 μg/ml). Compounds 3 was more active against Staphylococcus
epidermidis and Candida albicans with a MIC value of 12.5 μg/ml in boths cases. Compounds 3 had also interesting
antioxidant activity with an IC50 of 3.57 μg/ml compared to quercetin (1.04 μg/ml).
Conclusion: The overall results of this study provide evidence that the compound 3, isolated from A. ataxacantha,
exhibit antimicrobial activity against Gram-positive and Gram-negative bacteria and yeast, especially against C.
albicans.
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Background
Fabaceae, also known as Leguminosae represented by
730 genera like Stylosanthes, Tamarindus, Caesalpinia,
Acacia and over 19400 species [1]. Acacia is a cosmopol-
itan genus containing in excess 1200 species and the
highest density and the greatest diversity is found in
tropical and subtropical regions, but also found through-
out the world [2]. The aerial parts of different species of
the genus Acacia are widely used in folk medicine due
to their content of a variety of bioactive components
which are responsible for numerous pharmacological
properties such as hypoglycemic, anti-inflammatory, anti-
bacterial, antihypertensive, analgesic, anticancer and anti-
atherosclerotic [3]. Acacia ataxacantha is widespread in
much of sub-Saharan Africa. This species is a very thorny
shrub with the height of 5 to 8 m. The leaves are alternate,
with spine that carries 5 to 12 pairs of pinnae. On twigs,
spines are short, clearly pointing down. The fruit pods are
flattened, brownish red in the dry state. This specie has
been reported in Benin, Nigerian and Kenya for its use in
traditional medicine for the treatment of tooth decay,
dysentery, bronchitis, cough and joint pain [4–6]. To the
best of our knowledge, little phytochemical work has yet
been done on A. ataxacantha. In a previous work, we
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reported the antioxidant, antifungal, antibacterial activities
and toxicity of the bark extracts of this plant [7–9]. These
results suggests that this plant might contain bioactive
compounds that act as antimicrobial and antioxidant
agents. It has been reported that in vitro tests do not ne-
cessarily confirm that the plant extracts are effective drugs
or a suitable candidate for drug development, it provides a
basis for understanding the effectiveness of the plant and
leads in particular to the search for new active substances
[10]. Therefore, the aim of this study was to isolate bio-
active compound from A. ataxacantha barks and investi-
gate their antimicrobial and antioxidant activities.
Methods
Plant material
Acacia ataxacantha barks were obtained from Ouidah,
department of atlantic, South Bénin. Specimens were au-
thenticated by Dr. Yedomohan, Botanist from National
Herbarium of University of Abomey-Calavi. Voucher
specimen (AA 6509/ HNB) have been deposited at the
same Herbarium. The collected material was dried for
four weeks in laboratory (22 °C), grinded into fine powder,
and subjected to extraction.
Extraction and isolation
Dry powdered bark of A. ataxacantha (250 g) was suc-
cessively extracted three times (3 × 500 ml) for 72 h with
hexane, dichloromethane, ethyl acetate and methanol by
maceration at room temperature. The resulting extracts
were filtered, concentrated under reduced pressure, and
kept at 4 °C. The dichloromethane extract (2.5 g) was
chromatographed by gradient elution on an open col-
umn (Silica gel Si 60, 0.063–0.200, mesh) using the mix-
ture n-hexane/EtOAc and EtOAc-MeOH in increasing
polarity to yield 36 fractions. These fractions were as-
sembled into four fractions (A, B, C and D) according to
the chromatographic profile obtained after thin layer
chromatography (TLC) analysis. Fractions A (450 mg)
and B (250 mg), soluble in dichloromethane, were
recrystallized with methanol. The white precipitates
obtained were purified by successive washing with
methanol to obtain respectively compound 1 (25 mg)
and 2 (32 mg). Purification of fraction C was done
using preparative HPLC (Gilson VP 250/21, Nucleodur
100-5 C18ec, Macherey-Nagel, UV detection 220 and
254 nm) with a gradient elution 10:90 to 90:10 (solvent
A: H2O + 0.1 trifluoroacetic acid (TFA), B: AcN + 0.1
TFA) to obtain 7 mg of compound 3.
Chemical elucidation of compounds
Structural determination of the isolated compounds was
carried out by spectrophotometric methods (1D and 2D
NMR, mass and UV spectrometry). 1D (1H, 13C) and 2D
(COSY, NOESY, HSQC and HMBC) NMR spectrum
were recorded at room temperature with a Bruker NMR
spectrometer (400 MHz and 500 MHz), and mass spec-
tra were recorded using LC-ESI-MS.
Microbial strains
Bacterial cultures used in this study included Staphylococ-
cus aureus (ATCC 6538), Staphylococcus epidermidis (CIP
8039), Enterococcus faecalis (ATCC 29212), Methicillin-
Resistant Staphylococcus aureus and Pseudomonas
aeruginosa (CIP 82118), obtained from Laboratoire de
Biophotonique et Pharmacologie, University of Strasbourg,
France. Candida albicans (CIP 4872) culture used in the
present study was obtained from national laboratory of
drug control in Cotonou (Bénin). Bacterial were main-
tained on Mueller-Hinton agar (MHA) and yeast on
Sabouraud Dextrose Agar (SDA) at 4 °C. Sub-culturing
was done weekly. The cells were inoculated in MH broth
for bacteria (37 °C, 18 h) or SD broth for yeast (30 °C,
48 h) prior to the test.
Bioautography and identification of antimicrobial
compounds
This test was performed only on selected bacterial cul-
tures which were remarkably inhibited by dichlorometh-
ane and ethyl acetate extracts, according to a modified
version of the method of Srinivas et al., [11]. 10 μl of the
extracts (20 mg/ml) were applied on a chromatographic
plate (Pre-coated TLC-sheets ALUGRAM® silica gel 60
with fluorescent indicator UV254; layer thickness 0.20 mm
for analytical TLC) followed by elution with a mixture of
dichloromethane/methanol (98:2) and dried in air. The
plates were run in duplicate. The first plate was used as
the reference chromatogram. The spots in the chromato-
gram were visualized in UV chamber (wavelength 365 and
254 nm) and the plate was sprayed with sulfuric vanillin
reagent. Other plates were used for the bioautography.
The chromatograms were sprayed with bacterial culture
(106 CFU/ml) of S. aureus, Methicillin-resistant S. Aureus,
S. epidermidis, E. faecalis, P. aeruginosa and fungi culture
(2 × 105 CFU/ml) of C. albicans. Each plate was incubated
at (37 °C, 24 h) for bacteria and (30 °C, 48 h) for yeast.
The inhibition zones were visualized by spraying the plates
with p-iodonitrotetrazolium (INT, 2.0 mg/ml).
Disc diffusion assay
The experiment was performed according to the
method described by Qaralleh et al [12] with some
modifications. For the determination of antimicrobial
activity, cultures were adjusted to 106 CFU/ml for bac-
teria and 2 × 105 CFU/ml for yeast using 0.5 McFarland
standards. Subsequently, cultures were inoculated into
MHA for bacteria or SDA for yeast by spreading. The
stock solutions of tested compounds were prepared by
solubilizing 1 mg of compound in 50 μl of dimethyl
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sulfoxide 2.5 % (DMSO 2.5 %). Then, these solutions
were diluted in 950 μl of Mueller-Hinton broth for
bacteria and Sabouraud broth for yeast strain to obtain
1 mg/ml. The sterile discs of 6 mm of diameter were
impregnated with 100 μg (50 μl, 2 mg/ml) of each com-
pound. Discs of gentamicin (30 μg) and fluconazole
(25 μg) were used as standard antibacterial and antifun-
gal controls respectively. The plates were incubated at
37 °C, 24 h for bacteria and 30 °C, 48 h for yeast. The
diameters of inhibitory zones (including the diameter of
the discs) were measured after the incubation period
and values superior to 7 mm (D 7 mm) were consid-
ered as active against microorganisms. All experiments
were performed in triplicate and the antimicrobial
activity was expressed as the mean of inhibition zone
diameters.
Minimum inhibitory concentration
The two-fold serial microdilution method was used to
determine the minimum inhibitory concentration (MIC)
values of isolated compounds against microorganisms
[9]. 100 μl of isolated compound (100 μg/ml) and 50 μg/
ml of antimicrobial standards (Gentamicin, Fluconazol)
were serially diluted two-fold in triplicate with Mueller-
Hinton broth for antibacterial test and Sabouraud broth
for yeast test in 96-well microplates to make eight con-
centrations of isolated compound (0.78–100 μg/ml) and
standards (0.39–50 μg/ml). 100 μl of fresh culture of
bacteria (106 CFU/ml) and yeast (2 × 105 CFU/ml) were
added to each well. DMSO (2.5 %) was used as negative
control while gentamicin and fluconazole were used as
positive controls.
Minimum bactericidal and fungicidal concentration
The minimum bactericidal (MBC) and minimum fungi-
cidal concentration (MFC) of isolated compounds was
determined according to the method of Escalona-Arranz
et al [13]. To determine the MBC and MFC, aliquots of
20 μl from all dilutions not showing any growth of bac-
teria and yeast were inoculated on sterile MHA plates (for
bacteria) and SDA (for yeast) by spreading using swab
sticks. Inoculated plates were incubated at 37 °C for 24 h
for all bacteria, while those with yeast were incubated at
30 °C for 48 h. After incubation, the concentration at
which there is no visible growth on the agar plate was re-
corded as the minimal bactericidal concentration (MBC)
and minimal fungicidal concentration (MFC). The experi-
ment was carried out in triplicate.
Determination of MIC index
The MIC index (MBC/MIC) was calculated for each
isolated compound and positive control drug to deter-
mine whether a compound had bactericidal/fungicidal
(MBC/MIC ≤4) or bacteriostatic/fungistatic (4 <MBC/
MIC <32) effect [14].
In vitro antioxidant activity
The isolated compounds (2 mg) and quercetin (control)
were dissolved in 1 ml of methanol HPLC-grade.
Dilutions were performed to obtain a stock solution at
100 μg/ml. The antioxidant activity of isolated compounds
on the stable radical 2,2-diphenyl-1-picrylhydrazyl (DPPH)
was determined by the method developed by Danielle and
Lall [15], with slight modifications. In this method 96-well
plates were used. The stock solution (100 μl) of each
isolated compound and quercetin was added separately to
the wells in the top row. A two-fold serial dilutions was
performed to obtain a concentration range from 1.56 to
100 μg/ml. Finally, 200 μl of methanolic solution of
2,2-diphenyl-1-picrylhydrazyl (2 %) were introduced in
each well. The plates were allowed to develop in the
dark for 30 min before the measurement of the absorb-
ance at 517 nm using a Microplate Reader (Rayto-6500).
The capability of each compound and the standard to
scavenging the free radical was determined as inhibition
percentage using the following formula:
Inhibition percentage I%ð Þ ¼ ABlank– Asample
 
=ABlank
   100
ABlank is the absorbance of the control reaction (con-
taining all reagents except the test sample) Asample is the
absorbance of sample/standard.
The concentration of compound reducing 50 % of free
radical DPPH (IC50) was determined graphically. The
assay was replicated three times and results are expressed
as mean ± standard deviation.
Statiscal analysis
All experiments were conducted in triplicate and the re-
sults were expressed as means ± standard deviation. The




The fractionation of the dichloromethane extract of A.
ataxacantha using silica gel column chromatography led
to the isolation of three compounds (1–3) identified as
lupeol, betulinic acid and betulinic acid-3-trans-caffeate
(Fig. 1).
Compound 1: White powder, 1H NMR (400 MHz,
CDCl3): δH 0.72 (3H, s, H-24), 0.78 (3H, s, H-28), 0.81
(3H, s, H-25), 0.92 (3H, s, H-27), 0.97 (3H, s, H-23),
1.01 (3H, s, H-26), 1.66 (3H, s, H-30), 3.17 (1H, dd,
J = 11Hz, 5 Hz, H-3), 4.55 (1H, dd, J = 2.4Hz, 1.4 Hz,
H-29 α), 4.67 (1H, d, J = 2.4Hz, H-29 β). The 1H
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NMR spectrum of compound 1 revealed the presence
of seven tertiary methyl protons at δ 0.72, 0.78, 0.81,
0.92, 0.97, 1.01 and 1.66 (integrated for 3H- each). A
sextet of one proton at δ 2.37 assign to 19β-H is char-
acteristic of lupeol. The H-3 proton showed a split
doublet at δ 3.17 with a coupling constant of 11 Hz
and 5 Hz while, a pair of doublet at δ 4.55 and δ 4.67
(1H, each) was indicative of olefinic protons at (H-29
a & b). Compound 1 was identified as lupeol. All spec-
tral data were in agreement with literature [16–18].
Compound 2: White powder, 1H NMR (400 MHz,
CDCl3): δH 0.65 (3H, s, H-24), 0.76 (3H, s, H-25),
0.86 (3H, s, H-26), 0.93 (3H, s, H-23), 0.97 (3H, s,
H-27), 1.65 (3H, s, H-30), 3.32 (1H, m, H-3), 4.56
(1H, s, H-29 α). The 1H-NMR spectrum of com-
pound 2 exhibited signals for methyl groups at δ
0.65, 0.76, 0.86, and 0.93, 0.97 and 1.65. The 1H
NMR spectrum also displayed signals for olefinic
hydrogens at δ 4.69, δ 4.56 (2H, s) for H-29 and
hydrogen attached to carbon bearing OH (H-3) at δ
3.32 (1H, s), respectively. The spectral data of
compounds 2 were in agreement with previously
published data of betulinic acid [19, 20].
Compound 3: White amorphous powder. The
molecular formula of 3 determined to be C39H54O6
by positive mode LC-ESI-MS data at m/z 641.38035
[M +Na]+ (calcd for C39H54O6, 641.38035). The UV
spectrum exhibited absorption maxima at 245 and
320 nm, suggesting the presence of an aromatic ring
Table 1 NMR Spectroscopic Data (500 MHz, CDCl3) of compound
3 (betulinic acid-3-trans-caffeate)
Position Compound 3
δH (J in Hz) δC, type
1 1.73 (m), 1.07 (m) 39.2, CH2
2 1.68 (m), 1.68 (m) 24.6, CH2
3 4.57 (t, 5.1) 81.2, CH
4 – 38.3, C
5 0.91 (m) 55.7, CH
6 1.53 (m), 1.46 (m) 19, CH2
7 1.39 (m), 1.51 (m) 35.1, CH2
8 – 42.7, C
9 1.43 (m) 50.7, CH
10 – 34.6, C
11 1.12 (m), 1.46 (m) 21.8, CH2
12 1.26 (m), 1.74 (m) 26.4, CH2
13 2.39 (m) 39.0, CH
14 – 43.3, C
15 1.59 (m), 1.20 (m) 30.5, CH2
16 2.26 (m) 1.44 (m) 32.9, CH2
17 – 56.8, C
18 1.59(m) 49.5, CH
19 3.0(m) 47.1, CH
20 – 150, C
21 1.93 (m), 1.37 (m) 31.4, CH2
22 1.50 (m), 1.92 (m) 37.9, CH2
23 0.86 (s) 28.3, CH3
24 0.89 (s) 16.3, CH3
25 0.93 (s) 16.9, CH3
26 0.97 (s) 16.4, CH3
27 0.97 (s) 14.9, CH3
28 – 177.8, C
29 4.60, 4.57 (brs) 110, CH2
30 1.68 (s) 19.6, CH3
1′ – 128, C
2′ 7.07 (d, 1.2) 122.6, CH
3′ – 115.8, C
4′ – 146.1, C
5′ 6.86 (d, 8.0) 143.9, CH
6′ 6.99 (dd, 8.0, 1.2) 114.6, CH
7′ 7.53 (d, 15.9) 144.3, CH
8′ 6.24 (d, 15.9) 116.9, CH
9′ – 167.7, C
Assignments were based on 2D NMR including HSQC, HMBC and NOESY.
Well-resolved couplings are expressed with coupling patterns and coupling
constants in hertz in parentheses
Fig. 1 Isolated triterpenes from Acacia ataxacantha. (1): lupeol; (2):
Betulinic acid; (3): Betulinic acid-3-trans-caffeate
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in the molecule. 1H and 13C NMR spectral data were
resumed in Table 1. The 2D experiments (COSY,
NOESY, HSQC and HMBC) were performed using
standard Bruker programs.
The compound 3 was inferred to be a triterpene,
based on the 1H NMR spectrum with a broad range of
aliphatic signals including six methyl singlets and the
13C NMR spectrum with 30 carbons (Table 1). Further
investigation of 13C NMR spectrum revealed the
characteristic signals for carboxylic acid (δC 177.8),
vinyl carbons (quaternary C at δC 150.0 and CH2 at δC
110.0) as well as an oxygen-bearing methine (δC 81.2).
This information suggested that the compound 3 is a
derivative of betulinic acid bearing an additional aro-
matic ester moiety at C-3. The aromatic ester was
identfied as caffeate by 1H NMR displaying trans olefin
signal at δ 6.24 (d, J = 15.9 Hz). The compound 3 was
identified as betulinic acid-3-trans-caffeate, which was
confirmed by comparing its data to literature values
[21–23].
Antimicrobial activity
The bioautography technique has been used to identify
the bioactive constituents from A. ataxacantha extracts.
Inhibition zones of antimicrobial components were
observed as white spots on a purple red background
(Fig. 2). These white areas indicate the presence of anti-
microbial compounds which inhibit the growth of mi-
croorganisms which did not support the reduction of
INT to the coloured formazan [24]. In a previous study,
dichloromethane (DCM) extract demonstrated the low-
est MIC against S. aureus, methicillin-resistent S. aureus,
S. epidermidis, E. faecalis and P. aeruginosa [9]. Hence,
these bacteria were selected for the bioautography assay
to identify antimicrobial compounds. The bioautography
assay exhibited inhibition zones (Rf 0.59) for dichloro-
methane extract against both Gram positive (S. aureus,
methicillin-resistent S. aureus, S. epidermidis and E.
faecalis) and Gram negative (P. aeruginosa) (Fig. 2).
Interestingly, the bioautogram with C. albicans showed
inhibition zones at Rf 0.59 (Fig. 3) indicating the same
compound was responsible for the antifungal activity
against C. albicans.
Subsequently, an experiment was conducted to isolate
and identify the actives compounds. The isolated com-
pounds were investigated for their antimicrobial activity
against Gram-positive (S. aureus, methicillin-resistent S.
aureus, S. epidermidis and E. faecalis), Gram-negative
(P. aeruginosa) and yeast (C. albicans). The results
obtained with disc diffusion assay were presented in
Table 2. Only Compound 3 out of the isolated com-
pounds was active against all tested microorganisms
(Table 2). The diameter of inhibition of compound 3
ranged from 15.7 to 23.3 mm. The highest inhibitory
effect was observed against S. epidermidis with inhib-
ition diameter of 23.3 mm. Overall, the Gram-positive
bacteria showed a greater susceptibility to compound 3
while P. aeruginosa (Gram-negative) showed moderate
sensitivity. Compounds 1 and 2 did not inhibit the
growth of microorganisms at 100 μg/disc. Previous study
showed that compounds 1 and 2 were active against
Escherichia Coli, Bacillus Subtilis and Staphylococcus
aureus with MIC values ranged from 100 to 200 μg/ml
[25]. The negligible antimicrobial activity of compounds
1 and 2 could be explained by the concentration used.
Fig. 2 Bioautography of A. ataxacantha extracts. DCM: dichloromethane; AcoEt: Ethyle acetate; S.aureus: Staphylococcus aureus; S.am.r: Staphylococcus
aureus meticilline resistent; S. epidermidis: Staphylococcus epidermidis; E. feacalis: Enterococcus feacalis; P. aeruginosa: Pseudomonas aeruginosa.
White areas indicate where reduction of INT to the coloured formazan did not take place due to the presence of compounds that inhibited
the bacterial growth
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However, it was reported that betulinic acid was not ac-
tive against the Gram-positive, Gram-negative bacteria
and yeast [26].
The present study has also assessed the quantitative
antimicrobial activity of isolated compounds by determin-
ing their MIC, MBC and MFC. The results were reported
in Table 3. Many reports consider the antimicrobial activ-
ities of compounds to be significant if the MIC is 10 μg/
ml or lower, moderate if 10 ˂ MIC ≤ 100 μg/ml and low if
MIC ˃ 100 μg/ml [27, 28]. Referring to these criteria, the
tested compounds had moderate antimicrobial activity
with MICs ranged from 12.5 to 50 μg/ml. MBC and MFC
values varied between 25 to 50 μg/ml. Only compound 3
showed antimicrobial activity against tested microorgan-
isms at different level. This compound was active
against S. aureus and P. aeruginosa (MIC and MBC
were 25 μg/ml in both cases), methicillin-resitant S.
aureus and E. faecalis (MIC or MBC were 50 μg/ml in
both cases). The lowest MIC (12.5 μg/ml) of compound
3 was recorded against S. epidermidis with a MBC
value of 25 μg/ml. Aba et al., also demonstrated the
antimicrobial activity of the amyrenol, a triterpene isolated
from the roots of A. ataxacantha with MIC value of
12 μg/ml and MBC/MFC of 25 μg/ml against Bacillus
subtilis, Escherichia coli and Salmonella typhi [29]. Our
results and those obtained by Aba et al, demonstrated the
importance of triterpenes in the antimicrobial activity of
A. ataxacantha.
The mechanism of antibiosis of the compound 3 was
calculated using MIC index as described by Stefanovic
and Comic [14], to elucidate whether the observed
antibacterial effect was bactericidal or bacteriostatic.
Higher values of MBC and MFC than those of MIC
indicates the bacteriostatic or fungistatic nature of the
compound 3 against methicillin-resistant S. aureus, S.
epidermidis, E. faecalis and C. albicans. The same
values of MBC and MIC observed against S. aureus
(50 μg/ml) and P. aeruginosa (25 μg/ml) indicated the
bactericidal nature of compound 3. MIC and MBC
values of compound 3 were most interesting against
P. aeruginosa which is a Gram-negative bacterium.
Fig. 3 Bioautography of A. ataxacantha extracts sprayed with
Candida albicans inoculum. DCM: dichloromethane; AcoEt: Ethyle
acetate. White areas indicate where reduction of INT to the coloured
formazan did not take place due to the presence of compounds
that inhibited the bacterial growth
Table 2 Preliminary antimicrobial testing of isolated compounds (1–3) by determination the zone of inhibitory (mm)
Bacteria/Fungus 1 (100 μg.disc-1) 2 (100 μg.disc-1) 3 (100 μg.disc-1) Gentamicin(30 μg.disc-1) Fluconazole (25 μg.disc-1)
S. a NA NA 18.3 ± 0.1 22.5 ± 0.0 Nt
S.a.m.r NA NA 20.0 ± 0.1 18.5 ± 0.0 Nt
S. ep NA NA 23.3 ± 0.0 20.5 ± 0.0 Nt
E. f NA NA 21.0 ± 0.1 22.0 ± 0.0 Nt
P. a NA NA 15.3 ± 0.0 14.0 ± 0.1 Nt
C. a NA NA 15.7 ± 0.0 NT 13.7 ± 0.1
Each value is expressed as means (n = 3) ± standard deviation (SD)
S.a :Staphylococcus aureus;Samr: Staphylococcus aureus methicillin resistant; S.ep :Staphylococcus epidermidis; E.f: Enterococcus faecalis; P. a: Pseudomonas aeruginosa;
C. a: Candida albicans. 1: lupeol; 2: betulinic acid; 3: betulinic acid-3-trans-caffeate. NA: not actif; NT: not tested
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Several decades ago, the search for antimicrobials was
still focused on the discovery of natural compounds
able to inhibit Gram-negative bacteria, which are dan-
gerous and causing infectious diseases. The Gram-
negative cell wall (made up of lipopolysaccharide) is
complex and multilayered structure, which makes access
to membrane more restricted and barrier to many envir-
onmental substances including synthetic and natural anti-
biotics [30]. The results of this study indicate that the
compound 3, isolated from the bark of A. ataxacantha,
could be an agent able to cross this complex barrier. In
this study, compound 3 (betulinic acid-3-trans-caffeate) is
found more active than compound 2 (betulinic acid). This
observation is in accordance with the structure-activity re-
lationship as reported previously [20, 31].
Antioxidant activity
The antioxidant activity of isolated compounds (1–3)
were determined using DPPH method and the results
are reported in Table 4. Compounds 3 (betulinic acid-3-
trans-caffeate) had significant antioxidant activity with
an IC50 of 3.57 μg/ml compared to quercetin (control)
1.04 μg/ml. Compound 1 (lupeol) showed moderate ac-
tivity with an IC50 value of 16.77 μg/ml while compound
2 (betulinic acid) had weak DPPH scavenging activity
with an IC50 of 25.15 μg/ml. The antioxidant activity of
lupeol was previously reported [32, 33]. The interesting
antioxidant activity of compound 3 could be attributed
to the phenolic nature of the caffeate substituent. The
antioxidant activity of Alkyl caffeates have been also
reported [34].
Conclusion
The results of the present study showed that the
betulinic acid-3-trans-caffeate isolated from the bark
of A. ataxacantha possesses good antimicrobial and
antioxidant potency. This compound could be a candi-
date for structure-activity study in the case of the
development of novel antimicrobial agents with an
improved therapeutic index. This is the first report on
the presence of lupeol, betulinic acid and betulinic
acid-3-trans-caffeate in this specie. Further studies are
in progress to identify the synergy between the iso-
lated compounds and standard antibiotics.
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Table 3 Minimum inhibitory concentration (MIC) and Minimum
bactericidal and fungicidal concentrations (MBC, MFC) of
compound 3 from A. ataxacantha
Minimum inhibitory concentrations (μg/ml)
Microorganismsa Gram (+) bacteria Gram (-) bacteria Yeast
S. a S.a.m.r S. ep E. f P. a C. a
3b 50 25 12.5 25 25 12.5
Gentamicin 0.39 0.39 0.78 0.39 0.78 Nt
Fluconazole Nt Nt Nt Nt Nt 0.78
Minimum bactericidal and fungicidal (μg/ml)
3b 50 50 50 50 25 25
Gentamicin 0.78 1.56 1.56 0.78 1.56 Nt
Fluconazole Nt Nt Nt Nt Nt 1.56
MIC index
3b 1 2 4 2 1 2
Gentamicin 2 4 2 2 2 Nt
Fluconazole Nt Nt Nt Nt Nt 2
aS.a : Staphylococcus aureus; S.a.m.r : Staphylococcus aureus methicillin resitant;
S.ep : Staphylococcus epidermidis; E.f: Enterococcus faecalis; P.a: Pseudomonas
aeruginosa; C.a: Candida albicans
b3: betulinic acid-3-trans-caffeate
Nt: not tested. MIC, MBC or MFC of compounds 1 and 2 were not determined




1 16.77 ± 0.18
2 25.15 ± 0.01
3 3.57 ± 0.02
Reference
Qercetin 1.04 ± 0.01
The value of IC50 are expressed as means (n = 3) ± standard deviation (SD)
1: lupeol, 2: betulinic acid, 3: betulinic acid-3-trans-caffeate
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